Filing Details

Accession Number:
0001179110-18-006906
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-16 17:30:20
Reporting Period:
2018-05-14
Accepted Time:
2018-05-16 17:30:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1428336 Healthequity Inc HQY Services-Business Services, Nec (7389) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1614957 Ashley Dreier C/O Healthequity, Inc.
15 W. Scenic Pointe Dr., Ste. 100
Draper UT 84020
Executive, Vp, Cto And Cio No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-14 16,750 $1.50 49,939 No 4 M Direct
Common Stock Acquisiton 2018-05-14 3,000 $14.00 52,939 No 4 M Direct
Common Stock Acquisiton 2018-05-14 16,250 $24.36 69,189 No 4 M Direct
Common Stock Disposition 2018-05-14 32,300 $70.85 36,889 No 4 S Direct
Common Stock Disposition 2018-05-14 3,700 $71.77 33,189 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-05-14 16,750 $0.00 16,750 $1.50
Common Stock Stock Option (right to buy) Disposition 2018-05-14 3,000 $0.00 3,000 $14.00
Common Stock Stock Option (right to buy) Disposition 2018-05-14 16,250 $0.00 16,250 $24.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-05-09 No 4 M Direct
0 2024-07-30 No 4 M Direct
32,500 2026-03-23 No 4 M Direct
Footnotes
  1. The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2017, as amended on April 12, 2018.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.36 to $71.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.38 to $72.24, inclusive.
  4. The option is immediately exercisable.
  5. The option becomes exercisable as to 32,500 shares in two equal installments on March 23, 2019 and 2020.